Epizyme (EPZM) Tops Q3 EPS by 18c

November 3, 2016 8:18 AM EDT
Get Alerts EPZM Hot Sheet
Trade EPZM Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.42), $0.18 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $6.6 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment